Tower Research Capital LLC TRC boosted its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 1,083.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,626 shares of the medical instruments supplier’s stock after acquiring an additional 6,066 shares during the period. Tower Research Capital LLC TRC’s holdings in DENTSPLY SIRONA were worth $436,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. boosted its holdings in shares of DENTSPLY SIRONA by 0.7% in the 4th quarter. BlackRock Inc. now owns 14,169,813 shares of the medical instruments supplier’s stock valued at $932,797,000 after buying an additional 104,894 shares in the last quarter. Schroder Investment Management Group boosted its holdings in shares of DENTSPLY SIRONA by 20.2% in the 4th quarter. Schroder Investment Management Group now owns 2,028,700 shares of the medical instruments supplier’s stock valued at $133,549,000 after buying an additional 340,916 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of DENTSPLY SIRONA by 29.2% in the 4th quarter. Bank of New York Mellon Corp now owns 2,998,159 shares of the medical instruments supplier’s stock valued at $197,370,000 after buying an additional 676,932 shares in the last quarter. Rhumbline Advisers boosted its holdings in shares of DENTSPLY SIRONA by 1.7% in the 4th quarter. Rhumbline Advisers now owns 482,149 shares of the medical instruments supplier’s stock valued at $31,740,000 after buying an additional 8,193 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $315,000. Institutional investors own 96.05% of the company’s stock.
In related news, Director Eric Brandt sold 6,409 shares of the company’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $68.04, for a total value of $436,068.36. Following the completion of the sale, the director now owns 12,073 shares in the company, valued at approximately $821,446.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.99% of the stock is owned by corporate insiders.
XRAY has been the subject of several research analyst reports. Zacks Investment Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, October 30th. Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 target price for the company in a report on Monday, November 6th. HC Wainwright restated a “buy” rating and issued a $68.00 target price on shares of DENTSPLY SIRONA in a report on Monday, November 6th. Stifel Nicolaus upped their target price on shares of DENTSPLY SIRONA from $66.00 to $70.00 and gave the company a “buy” rating in a report on Monday, November 6th. Finally, TheStreet upgraded shares of DENTSPLY SIRONA from a “c” rating to a “b-” rating in a report on Friday, November 3rd. Three analysts have rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $69.15.
Shares of DENTSPLY SIRONA Inc (NASDAQ XRAY) opened at $57.11 on Friday. DENTSPLY SIRONA Inc has a 12-month low of $52.53 and a 12-month high of $68.98. The company has a market cap of $13,335.39, a price-to-earnings ratio of 23.13, a P/E/G ratio of 2.14 and a beta of 1.18. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.32 and a quick ratio of 1.59.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be given a $0.0875 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $0.35 annualized dividend and a yield of 0.61%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -10.09%.
COPYRIGHT VIOLATION NOTICE: This story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another website, it was illegally copied and reposted in violation of international trademark and copyright legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/23/tower-research-capital-llc-trc-has-436000-holdings-in-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.